S Tsourlos

University of Ioannina — Greece

Medicine · Health Sciences

3h-index114citations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Blood Pressure and Hypertension Studies(7), COVID-19 Clinical Research Studies(4), Diabetes, Cardiovascular Risks, and Lipoproteins(3), Diabetes Treatment and Management(3), Pharmacology and Obesity Treatment(2)

Publications11 total

Correlation of Lymphocyte Subpopulations, Clinical Features and Inflammatory Markers during Severe COVID-19 Onset
Pathogens·2023· 6 citedOpen Access
Laboratory findings and clinical outcomes of 681 COVID-19 patients with dyslipidemia requiring hospitalization
Atherosclerosis·2022Open Access
Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients
Atherosclerosis·2022Open Access
Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients
Atherosclerosis·2022Open Access
Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with delapril/manidipine in prediabetic hypertensive patients
European Journal of Preventive Cardiology·2022Open Access
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with manidipine/delapril in prediabetic hypertensive patients
European Journal of Preventive Cardiology·2022Open Access
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with telmisartan/amlodipine in prediabetic patients
European Journal of Preventive Cardiology·2022Open Access
Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with valsartan/amlodipine in prediabetic hypertensive patients
European Journal of Preventive Cardiology·2022Open Access
Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with telmisartan/amlodipine in prediabetic hypertensive patients
European Journal of Preventive Cardiology·2022· 1 cited
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients
European Journal of Preventive Cardiology·2022Open Access
Baseline characteristics and outcome predictors in patients hospitalized with COVID-19 in the University General Hospital of Ioannina, Greece
Pneumon·2022· 3 citedOpen Access

Frequent Co-authors

Angelos Liontos(11), Dimitrios Biros(11), Lazaros Athanasiou(11), Eirini Christaki(11), Αθανάσιος Παπαθανασίου(9), Evangelos Liberopoulos(9), Christos Papagiannopoulos(8), Athina Zarachi(8), Moses Elisaf(8), Georgé Liamis(8), C Veliani(7), Christina Pappa(7), Eleni Pargana(5), Maria Nasiou(5), Haralambos Milionis(5), NG Kolios(4), Ilias Tsiakas(3), Haralampos Milionis(3), H. Milionis(3), Nikolaos-Gavriel Kolios(3)